Cargando…

Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype

GAD-alum given into lymph nodes to Type 1 diabetes (T1D) patients participating in a multicenter, randomized, placebo-controlled double-blind study seemed to have a positive effect for patients with DR3DQ2 haplotype, who showed better preservation of C-peptide than the placebo group. Here we compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puente-Marin, Sara, Dietrich, Fabrícia, Achenbach, Peter, Barcenilla, Hugo, Ludvigsson, Johnny, Casas, Rosaura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933867/ https://www.ncbi.nlm.nih.gov/pubmed/36817467 http://dx.doi.org/10.3389/fimmu.2023.1112570

Ejemplares similares

Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes
por: Tavira, Beatriz, et al.
Publicado: (2018)

Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients
por: Casas, Rosaura, et al.
Publicado: (2020)

Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2
por: Nowak, Christoph, et al.
Publicado: (2022)

Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)
por: Casas, Rosaura, et al.
Publicado: (2022)

Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes
por: Barcenilla, Hugo, et al.
Publicado: (2022)

Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
por: Ludvigsson, Johnny, et al.
Publicado: (2021)

Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes
por: Barcenilla, Hugo, et al.
Publicado: (2019)

Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol
por: Ludvigsson, Johnny, et al.
Publicado: (2022)

Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes
por: Hannelius, Ulf, et al.
Publicado: (2020)

The likelihood ratio and frequency of DQ2/DQ8 haplotypes in Iranian patients with celiac disease
por: Khosravi, Asghar, et al.
Publicado: (2016)

Intralymphatic immunotherapy
por: Senti, Gabriela, et al.
Publicado: (2015)

Intralymphatic Histiocytosis
por: Garcia-Mouronte, Emilio, et al.
Publicado: (2022)

Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type I diabetes: lessons from the DIABGAD randomized pilot trial
por: Ludvigsson, Johnny, et al.
Publicado: (2020)

Selection assisted by a BoLA-DR/DQ haplotype against susceptibility to bovine dermatophilosis
por: Maillard, Jean-Charles, et al.
Publicado: (2003)

Human Leukocyte Antigen DQ (HLA‐DQ) genotypes and haplotypes and their association with phenotype in patients with celiac disease in India
por: Ramakrishna, Balakrishnan S, et al.
Publicado: (2021)

Prevalence of haplotype DQ2/DQ8 and celiac disease in children with type 1 diabetes
por: Zubkiewicz-Kucharska, Agnieszka, et al.
Publicado: (2022)

HLA-DQ2 and -DQ8 haplotypes frequency and diagnostic utility in celiac disease patients of Gaza strip, Palestine
por: Ayesh, Basim M., et al.
Publicado: (2017)

The frequency of HLA-DQ2/DQ8 haplotypes and celiac disease among the first-degree relatives of patients with celiac disease
por: Mansouri, Masoume, et al.
Publicado: (2021)

Association of HLA-DR/DQ polymorphisms with schizophrenia in Tunisian patients
por: Sayeh, Aicha, et al.
Publicado: (2014)

Association between treatment effect on C‐peptide preservation and HbA1c in meta‐analysis of glutamic acid decarboxylase (GAD)‐alum immunotherapy in recent‐onset type 1 diabetes
por: Nowak, Christoph, et al.
Publicado: (2022)

Intralymphatic Histiocytosis: An Unusual Presentation
por: Blackwell, Timothy J., et al.
Publicado: (2021)

The HLA-B*3906 allele imparts a high risk of diabetes only on specific HLA-DR/DQ haplotypes
por: Baschal, E. E., et al.
Publicado: (2011)

Frequency of celiac disease and distribution of HLA-DQ2/DQ8 haplotypes among siblings of children with celiac disease
por: Sahin, Yasin, et al.
Publicado: (2022)

HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children
por: Stanevicha, Valda, et al.
Publicado: (2007)

Associations of HLA DR and DQ molecules with Lyme borreliosis in Latvian patients
por: Kovalchuka, Lilija, et al.
Publicado: (2012)

Haplotype analysis of DQ2.5 and DQ8 by simple nucleotide polymorphism technique (TAG-SNP) in type 1 diabetes and/or celiac disease patients
por: Bastos, Marília Dornelles, et al.
Publicado: (2015)

Trends in the Frequency of HLA DR-DQ Haplotypes Among Children and Adolescents with Type 1 Diabetes Mellitus in the Southeast Region of Turkey
por: Keskin, Mehmet, et al.
Publicado: (2012)

The Transplantability of Tumours by Intravenous and Intralymphatic Routes
por: Wallace, A. C., et al.
Publicado: (1965)

Papillary intralymphatic angioendothelioma: Dabska tumor()()
por: Silva, Thadeu Santos, et al.
Publicado: (2020)

Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children
por: Zhao, Lue Ping, et al.
Publicado: (2020)

Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients
por: Thevarkalam, Meena, et al.
Publicado: (2023)

Capture of Type 1 Diabetes–Susceptible HLA DR-DQ Haplotypes in Japanese Subjects Using a Tag Single Nucleotide Polymorphism
por: Nakanishi, Koji, et al.
Publicado: (2010)

Human leukocyte antigen (HLA)-DQ2 and -DQ8 haplotypes in celiac, celiac with type 1 diabetic, and celiac suspected pediatric cases
por: Siddiqui, Komal, et al.
Publicado: (2021)

Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial
por: Axelsson, Stina, et al.
Publicado: (2013)

Three Distinct Glutamate Decarboxylase Genes in Vertebrates
por: Grone, Brian P., et al.
Publicado: (2016)

Molecular Analysis of Glutamate Decarboxylases in Enterococcus avium
por: Gu, Xinyi, et al.
Publicado: (2021)

The disposition of cytotoxic agents after intralymphatic infusion.
por: Calnan, J. S., et al.
Publicado: (1967)

Papillary intralymphatic angioendothelioma: An extremely rare tumor
por: Kaplan, Güven Ozan, et al.
Publicado: (2021)

Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets
por: Magnusson, Louise, et al.
Publicado: (2020)

Peptide binding predictions for HLA DR, DP and DQ molecules
por: Wang, Peng, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2gm4itme43ud6c5vlg8asnt1md